High glucose dialysate-induced peritoneal fibrosis: Pathophysiology, underlying mechanisms and potential therapeutic strategies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

High glucose dialysate-induced peritoneal fibrosis: Pathophysiology, underlying mechanisms and potential therapeutic strategies

Published:2023-09 Issue: Volume:165 Page:115246
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Zhao Hanxue,Zhang Hong-Liang,Jia Linpei^ORCID

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference145 articles.

1. Peritoneal dialysis;Teitelbaum;N. Engl. J. Med.,2021

2. Antifibrotic agents for the management of CKD: a review;Ruiz-Ortega;Am. J. Kidney Dis.,2022

3. Peritoneal dialysis;Andreoli;Rev. Assoc. Med. Bras.,2020

4. A review on major pathways leading to peritoneal fibrosis in patients receiving continuous peritoneal dialysis;Taheri;Cureus,2022

5. Biocompatible dialysis fluids for peritoneal dialysis;Htay;Cochrane Database Syst. Rev.,2018

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peritoneal fibrosis: from pathophysiological mechanism to medicine;Frontiers in Physiology;2024-09-04

2. JPH203 alleviates peritoneal fibrosis via inhibition of amino acid-mediated mTORC1 signaling;Biochemical and Biophysical Research Communications;2024-09

3. Rationale and design of ELIXIR, a randomized, controlled trial to evaluate efficacy and safety of XyloCore, a glucose-sparing solution for peritoneal dialysis;Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis;2024-08-28

4. Selective therapeutic efficacy of tyrosine kinase inhibitor sorafenib on the restoration of methylglyoxal-induced peritoneal fibrosis;Biomedicine & Pharmacotherapy;2024-07

5. Dialysate cyclophilin A as a predictive marker for historical peritonitis in patients undergoing peritoneal dialysis;Heliyon;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3